和誉-B(02256):和誉医药于2026年AACR年会展示六项研究进展,聚焦pan-KRAS、四代EGFR及合成致死等创新路线
Last Update:
23 4 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.